Investigating the effects of vaping nicotine and cannabis in young people
Official title: Vaping Nicotine and Cannabis Across Adolescence and Young Adulthood
Funded at University of Southern California · NIH-10926856 · Data updated 2026-11-12
This study is looking at how vaping nicotine and cannabis impacts young people aged 12 to 20, to see if it leads to more smoking or if it’s linked to other challenges they might be facing, with the goal of helping to create better health strategies for them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project start | September 20, 2019 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $377,995 |
| NIH project number | 5R01CA229617-06 |
| Project ID | NIH-10926856 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adolescents and young adults aged 12 to 20 who are currently using or have used vaping products.
✕Less likely to help
Patients who are not within the age range of 12 to 20 or who do not engage in vaping may not benefit from this research.
What this research studies
This research explores how vaping nicotine and cannabis affects adolescents and young adults, particularly those aged 12 to 20. It aims to understand whether vaping leads to increased smoking or reflects existing behavioral issues among high-risk youth. The study will examine various vaping products and their potential addictive qualities, as well as the social and psychological factors that influence vaping behaviors. By gathering data on these aspects, the research seeks to inform public health strategies and prevention efforts.
Why it matters
Potential benefit: If successful, this research could lead to more effective prevention strategies for vaping and smoking among young people.
How similar studies have gone: Previous research has indicated concerns about vaping among adolescents, but this specific approach using the catalyst model is relatively novel.
Where this research is happening
-
University of Southern California
Los Angeles, United States Active
Researchers
- Principal investigator: Leventhal, Adam Matthew — University of Southern California
- Study coordinator: Leventhal, Adam Matthew
Related research
Other NIH-funded projects on the same topics.
-
Helping Parents Prevent Adolescent Vaping: A Longitudinal Study and Experimental Messages
A study with 12-year-olds’ families aims to understand how parental knowledge and parenting practices influence teens’ nicotine and cannabis vaping, and tests messages to help parents prevent vaping.
-
Chemicals released by vaping cannabis
This work looks at which chemicals are produced when people vape concentrated cannabis and how different devices and formulations change those emissions, with special attention to risks for young users.
-
Investigating the chemicals and toxic emissions from cannabis vaping
This study is looking at how vaping cannabis affects health, especially for young people, by figuring out what harmful chemicals are released when different types of cannabis and vaporizers are used, so we can better understand the safety of these products.
-
Understanding how young adults use nicotine and cannabis together
This study is looking at how young adults who use both nicotine and cannabis through vaping are affected by it in their daily lives, aiming to understand how these substances work together and impact their health and happiness.
-
How local tobacco and cannabis stores affect teen vaping habits
This study looks at how having more tobacco and cannabis shops close to homes and schools affects young people's vaping habits, especially if they live in less advantaged neighborhoods, to help create better policies to reduce vaping among teens.
-
Hemp-derived CBD for reducing cannabis use in high-THC concentrate users
A randomized, placebo-controlled trial tests whether hemp-derived CBD can help adults who mainly use high-potency cannabis concentrates reduce their cannabis use.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.